Rwanda initiates its vaccination campaign against the Marburg virus (Image from Pixabay) 
Medicine

Rwanda Begins Marburg Vaccinations to Curb Deadly Outbreak

Rwanda Launches Urgent Vaccination Campaign Against Marburg Virus After 12 Deaths, Targeting At-Risk Populations

MBT Desk

Rwanda said Sunday it had begun administering vaccine doses against the Marburg virus to try to combat an outbreak of the Ebola-like disease in the east African country, where it has so far killed 12 people.

"The vaccination is starting today immediately," Health Minister Sabin Nsanzimana said at a news conference in the capital Kigali.

He said the vaccinations would focus on those "most at risk, most exposed health care workers working in treatment centers, in the hospitals, in ICU, in emergency, but also [in] the close contacts of the confirmed cases."

The country has already received shipments of the vaccines including from the Sabin Vaccine Institute.

Rwanda's first outbreak of the viral hemorrhagic fever was detected in late September, with 46 cases and 12 deaths reported since then. Marburg has a fatality rate as high as 88%.
Marburg symptoms include high fever, severe headaches and malaise within seven days of infection and later severe nausea, vomiting and diarrhea.

It is transmitted to humans by fruit bats and then spreads through contact with the bodily fluids of those infected. Neighboring Uganda has suffered several outbreaks in the past.

Marburg virus is transmitted to humans by fruit bats (Image from Pixabay)

"We believe that with vaccines, we have a powerful tool to stop the spread of this virus," the minister said.

VOA/SP

When You’re Caught Between ‘Yes’ and ‘No,’ Here’s Why ‘Maybe’ Isn’t the Way to Go

Sophont, Founded by 22-Year-Old Innovator, Raises $9.22M Seed Round to Transform Healthcare with Multimodal AI

Doctor Arrested in Goa for Alleged Assault on Moroccan Patient in ICU

Hyderabad Man Contracts Hepatitis A After Eating Panipuri, Misses Work for 30 Days

Biotech Creates, Bioinformatics Decodes: Which Field Holds the Future of Life Sciences?